Civil society group SAM calls for greater transparency involving clinical trials
The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…
Different packaging, typos expose fake Mounjaro racket
Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…
To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book
New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…
Rajasthan Bans 7 Sub-Standard Medicines
Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality”. Prioritising…
ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection
OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…
Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…
Obesity drug market to gain as Indians pop the pill and Chinese bring more
Mumbai: A flood of oral GLP1 weight-loss pills, including from China, may redraw India’s obesity treatment market by this year-end, said industry executives and top endocrinologists. Nearly a dozen oral…
Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23
New Delhi: Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…
Boehringer Ingelheim launches AI centre for pharma research in London
Bengaluru: German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning in London, it said on Monday, as it seeks to expand its AI capabilities in…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…
